Given the common use of ACE inhibitors and ARBs worldwide, guidance on the use of these drugs in patients with Covid-19 is urgently needed. Here, we highlight that the data in humans are too limited ...
With the cloud becoming the primary means of accessing a growing number of software offerings, it seems like every application is migrating to an “as-a-service” delivery model these days. So it should ...
Treatments that target the renin-angiotensin-aldosterone system (RAAS) don’t improve outcomes in adult patients hospitalized with acute COVID-19. Three separate trials of different RAAS-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results